We use cookies to enable the functions required for this website, such as login or a shopping cart. You can find more information in our privacy policy.
Frank Schwarz has a postgraduate degree in Oral Surgery and is Professor and Head of the Department of Oral Surgery and Implantology at the Centre for Dentistry and Oral Medicine (Carolinum), Johann Wolfgang Goethe-University Frankfurt, Germany. He serves as an Associate Editor for the Journal of Clinical Periodontology and Editorial Board Member for Clinical Oral Implants Research. He is the President of the German Association of Oral Implantology (DGI), a Board Member of the Osteology Foundation and was awarded the André Schröder Research Prize in 2007, the Miller Research Prize in 2012 and the Jan Lindhe Award in 2017.
1. Auflage 2009 DVD 2 DVDs in Amaray-Box, Laufzeit: 110 Min. Language: German Category: Implantology Stock No.: 5869 ISBN 978-3-938947-99-9 QP Deutschland
Ätiologie, Pathogenese, Diagnostik und aktuelle Therapiekonzepte
1. Auflage 2007 Book Hardcover, 272 pages, 510 illus Language: German Categories: Implantology, Oral Surgery, General Dentistry Stock No.: 13880 ISBN 978-3-938947-32-6 QP Deutschland
Regeneration and Esthetics in Periodontology and Implant Dentistry02.12.2022 — 03.12.2022Congress Center, Kursaal Bern, Bern, Switzerland
Speakers: Sofia Aroca, Daniel Buser, Stephen Chen, Massimo De Sanctis, Nikolaos Donos, Markus B. Hürzeler, Sascha Jovanovic, Ronald E. Jung, Giulio Rasperini, Isabella Rocchietta, Frank Schwarz, Anton Sculean, Shakeel Shahdad, Andreas Stavropoulos, Martina Stefanini, Leonardo Trombelli, Istvan Urban, Giovanni Zucchelli
Buser & Sculean Academy
3rd Urban International Hard and Soft Tissue Regeneration Symposium
Predictability in Regeneration21.10.2022 — 22.10.2022Budapest Congress Center, Budapest, Hungary
Speakers: José Carlos da Rosa, Luca De Stavola, Ueli Grunder, Jaime Lozada, Ausra Ramanauskaite, Frank Schwarz, Istvan Urban, Giovanni Zucchelli, Otto Zuhr
Urban Regeneration Institute
7 Decades of Quintessence Publishing
10.01.2019 — 12.01.2019Estrel Convention Center
Speakers: Jiro Abe, Michèle Aerden, Wael Att, Stavros Avgerinos, Avijit Banerjee, Vesna Barac Furtinger, Klaus-Dieter Bastendorf, Lars Bergmans, Ashwini Bhalerao, Jaroslav Bláha, Sebastian Bürklein, Daniel Buser, Josette Camilleri, Sevim Canlar, Sandra Chmieleck, Bun San Chong, Victor Clavijo, Carsten Czerny, Bettina Dannewitz, Alessandro Devigus, Didier Dietschi, Irina Dragan, Daniel H.-J. Edelhoff, Peter Eickholz, Karim Elhennawy, Peter Engel, Wolfgang Eßer, Marco Esposito, Susanne Fath, Vincent Fehmer, Federico Ferraris, Stefan Fickl, Mauro Fradeani, Roland Frankenberger, Eiji Funakoshi, Petra Gierthmühlen, Christiane Gleissner, Florian Göttfert, Dennis Grosse, Galip Gürel, Christian Haase, Horst-Wolfgang Haase, Manuela Hackenberg, Jörg Haist, Anke Handrock, Arndt Happe, Karsten Heegewaldt, Rüdiger Henrici, Michael Hülsmann, Hajime Igarashi, Tomohiro Ishikawa, Hideaki Katsuyama, Kathryn Kell, Matthias Kern, Fouad Khoury, Marko Knauf, Ralf Kohal, Stefen Koubi, Fabian Langenbach, Henriette Terezia Lerner, Thomas Malik, Siegfried Marquardt, Henrike März, Kathleen Menzel, Helen Möhrke, Kotaro Nakata, Marc L. Nevins, Masayuki Okawa, Rebecca Otto, Mark Stephen Pace, Shanon Patel, Karin Probst, Domenico Ricucci, Katrin Rinke, Irena Sailer, Edgar Schäfer, Ralf Schäfermeier, Jan Schellenberger, Tom Schloss, Gottfried Schmalz, Devorah Schwartz-Arad, Frank Schwarz, Thomas A. Schwenk, Anton Sculean, Bernd Stadlinger, Athanasios Stamos, Ana Stevanovic, Masana Suzuki, Senichi Suzuki, Hiroyuki Takino, Sameh Talaat, Mitsuhiro Tsukiboshi, Hideaki Ueda, Istvan Urban, Luc W.M. van der Sluis, Eric van Dooren, Bart Van Meerbeek, Paula Vassallo, Juliane von Hoyningen-Huene, Michael Walter, Siegbert Witkowski, Stefan Wolfart, Sylvia Wuttig, Masao Yamazaki, Maciej Zarow, Matthias Zehnder, Raquel Zita Gomes, Giovanni Zucchelli, Otto Zuhr, Bettina Zydatiß
Quintessenz Verlags-GmbH
Deutscher Zahnärztetag 2018
MISSERFOLGE - erkennen, beherrschen, vermeiden09.11.2018 — 10.11.2018Congress Center Messe Frankfurt
Speakers: Karl-Ludwig Ackermann, Sarah Al-Maawi, Bilal Al-Nawas, Kurt Werner Alt, Anna Greta Barbe, Tobias Bauer, Daniel Bäumer, Marco Baz Bartels, Grietje Beck, Katrin Bekes, Christoph Benz, Dirk Bleiel, Johannes Boesch, Martin Boost, Wolfgang Buchalla, Oskar Bunz, Fabian Cieplik, Monika Daubländer, Sybille David, Andreas Dehler, Renate Deinzer, Sonja H. M. Derman, Konstanze Diekmeyer, Ingmar Dobberstein, Heike Dyrna, Thomas Eger, Guido Elsäßer, Anne Sophie Engel, Peter Engel, Norbert Enkling, Susanne Fath, Stefan Fickl, Michael Frank, Roland Frankenberger, Rene Franzen, Kerstin Galler, Carolina Ganß, Roland Garve, Christian Ralf Gernhardt, Werner Geurtsen, Shahram Ghanaati, Petra Gierthmühlen, Christiane Gleissner, Werner Götz, Susanne Grässel, Dominik Groß, Stefan Grümer, Claus Grundmann, Martin Guffart, Heinz-Michael Günther, Norbert Gutknecht, Peter Hahner, Elmar Hellwig, Christian Henrici, Katrin Hertrampf, Fabian Huettig, Michael Hülsmann, Bruno Imhoff, Steffani Janko, Holger Jentsch, A. Rainer Jordan, Ana Elisa Kauling, Moritz Kebschull, Christian Kirschneck, Joachim Klimek, Andrea Klink, Thomas Klinke, Birte Koch, Thomas Kocher, Eva Köllensperger, Heike Maria Korbmacher-Steiner, Bernd Kordaß, Hannah Kottmann, Pablo Krämer-Fernandez, Gabriel Krastl, Birgit Krause, Till Kreutzer, Conrad Kühnöl, Stefanie Kurzschenkel, Thorsten Kuypers, Günter Lauer, Hans-Christoph Lauer, Elfi Laurisch, Tina Lawall, Karl Martin Lehmann, Silke Lehmann-Binder, Dirk Leisenberg, Ulrike Lübbert, Michael Lüpke, Thomas Malik, Jutta Margraf-Stiksrud, Lorenz Meinel, Gudrun Mentel, Wibke Merten, Louisa Mewes, Johanna Isabel Moosmüller, Martin U. Müller, Wolfgang Müller, Nicole Nicklisch, Ina Nitschke, Michael J. Noack, Marina Nörr-Müller, Karina Obreja, Dietmar Oesterreich, Puria Parvini, Ingrid Peroz, Waldemar Petker, Oksana Petruchin, Andree Piwowarczyk, Peter Pospiech, Peter Proff, Sven Reich, Katharina Reichenmiller, Katharina Reinecke, Bernd Reiss, Svenja Rink, Christiane Rinnen, Jerome Rotgans, Sebastian Ruge, Didem Sahin, Sonja Sälzer, Petra Santander, Heidrun Schaaf, Jürgen Schäffer, Elisabeth Schiffner, Ulrich Schiffner, Markus Schlee, Maximiliane Amelie Schlenz, Peter Schmidt, Andrea-Maria Schmidt-Westhausen, Claas Ole Schmitt, Sigmar Schnutenhaus, Jörg Schröder, Gerd Schröter, Andreas Schulte, Philipp Schwaab, Frank Schwarz, Falk Schwendicke, Clemens Schwerin, Sinan Sen, Önder Solakoglu, Hansmartin Spatzier, Christian H. Splieth, Norbert Staab, Bernd Stadlinger, Sabine Steding, Marcus Stoetzer, Giorgio Tabanella, Gisela Tascher, Hendrik Terheyden, Valentina A. Tesky, Jan Tetsch, Juliane von Hoyningen-Huene, Maximilian Voß, Michael Walter, Alexander Welk, Dietmar Weng, Hans-Jürgen Wenz, Jens Westemeier, Lotta Westphal, Annette Wiegand, Karl Frederick Wilms, Michael M. Wolf, Diana Wolff, Anne Wolowski, Johann-Dietrich Wörner, Sylvia Wuttig, Mohamed Younis, Stefan Zimmer, Lisa Zumpe
Quintessenz Verlags-GmbH
This author's journal articles
International Journal of Periodontics & Restorative Dentistry, 5/2022
Immediate implant placement with immediate restoration in the esthetic zone is a standardized protocol that aims to satisfy the patient with an immediate, esthetic rehabilitation. This study evaluated clinical and esthetic outcomes following immediate implant placement and provisionalization over a medium- to long-term period. A total of 57 implants in 44 patients were included in the present cross-sectional study, with a follow-up period of 3.97 ± 2.03 years. Surgical and prosthetic treatments were performed according to a standardized protocol. Clinical outcomes (modified Plaque Index, bleeding on probing, probing depth [PD], keratinized mucosa, mucosal recession [MR], and pink esthetic score [PES]) were evaluated during follow-up. Peri-implant tissue health was assessed based on the established case definitions. The mean PES value at the final control examination (mean PES follow-up time: 3.79 ± 1.85 years) was 12.06, the mean PD was 2.52 ± 0.88 mm, and mean MR was 0.03 ± 0.13 mm. No suppuration, pain, or implant or prosthetic failures were reported. The prevalence rates of mucositis and peri-implantitis were 45.5% and 0%, respectively. Immediate implant placement and restoration was associated with peri-implant tissue stability and esthetics over medium- and long-term follow-up periods.
Purpose: To assess the clinical performance of a two-piece zirconia implant system (PURE Ceramic Implants, Straumann, Basel, Switzerland) in the maxilla after a follow-up period of more than 1 year.
Materials and methods: A total of 19 patients in three centres received 24 single-tooth implants in the maxilla. The implants were restored after a mean healing period of 7.1 ± 0.4 months (range 7 to 9 months). Implant survival, implant success, Plaque Index, probing pocket depth, bleeding on probing, mucosal recession/creeping attachment, width of keratinised mucosa, papilla index and pink aesthetic score were evaluated after prosthetic loading (T0), after 6 months (T1) and at the final follow-up (T2, mean 15.0 ± 2.1 months, range 12 to 19 months).
Results: All implants survived and were suitable for retaining prostheses. Low values were recorded for Plaque Index (0.38 ± 0.68) and probing pocket depth (2.49 ± 0.49 mm). Bleeding on probing increased significantly from T0 (21.7%) to T1 (50.0%) (P = 0.0342) and then remained stable (50.0% at T2). No recession was detected around any of the implants. A statistically significant increase in attachment level was observed from T0 to T2 (0.79 ± 0.88 mm; P = 0.0196). A papilla index of 2.27 ± 0.81 and pink aesthetic score of 11.67 ± 1.60 at T2 indicated a completely satisfying aesthetic result.
Conclusion: Within the limitations of the present study, the two-piece zirconia implant system investigated achieved fully satisfying functional and aesthetic results.
Keywords: ceramic implant, maxilla, multicentre study, two-piece ceramic implant, zirconia implant
Conflict-of-interest statement: Drs Linder and Dard are employees of Straumann Group (Basel, Switzerland). The other authors report no conflicts of interest relating to this study.
Das Ziel dieser retrospektiven Analyse war es zu evaluieren, wie hoch das intra- und postoperative Komplikationsrisiko bei intravenösen (i. v.) Sedierungen mit Midazolam bei ambulanten oralchirurgischen und implantologischen Eingriffen ist, wenn die Patientenselektionskriterien eingehalten werden und die Sedierung durch ein zahnärztliches, geschultes Behandlungsteam durchgeführt wird. Insgesamt wurden 231 Patienten in die retrospektive Analyse eingeschlossen. Dokumentiert wurden die allgemeine Anamnese, die Klassifikation nach der American Society of Anesthesiologists (ASA), die Art des operativen Eingriffs, die verabreichte Initial- und die Gesamtdosis des Benzodiazepins, die Art und Menge des verwendeten Lokalanästhetikums, die Dauer der Sedierung und die Vitalparameter sowie das Auftreten von Komplikationen im Rahmen der Sedierung. Die Patienten im Alter von 12−80 Jahren (Durchschnittsalter 36,1 ± 17,5 Jahre) wurden zu 66,2 % der ASA-Klasse 1 und 33,8 % der ASA-Klasse 2 zugeordnet. Bei insgesamt fünf (2,2 %) Patienten wurden Komplikationen intra- oder postoperativ im Rahmen der durchgeführten i. v. Sedierung mit Midazolam beobachtet. Verglichen mit den komplikationslosen Eingriffen wurde kein signifikanter Unterschied in Bezug auf die Allgemeinanamnese, die ASA-Klassifizierung, die Vitalparameter, die Dosis des Benzodiazepins und die Art oder Menge des Lokalanästhetikums festgestellt. Statistisch signifikant war der Unterschied zwischen den Patientengruppen mit und ohne Komplikationen hinsichtlich des Körpergewichts (p < 0,019), jedoch spiegelte sich diese Signifikanz nicht im Körper-Masse-Index (BMI) wider. Das Komplikationsrisiko im Rahmen von i. v. Sedierungen bei oralchirurgischen und implantologischen Eingriffen fällt durch eine adäquate Patientenauswahl gering aus.
Manuskripteingang: 11.04.2022, Annahme: 10.06.2022
Keywords: intravenöse Sedierung, Midazolam, Flumazenil
Peri-implantitis is an infectious disease that leads to progressive bone loss. Surgical therapy has been advocated as a way of halting its progression and re-establishing peri-implant health. One of the most challenging but crucial tasks in the management of peri-implantitis is biofilm removal to achieve reosseointegration and promote the reduction of peri-implant pockets. A wide variety of strategies have been used for implant surface decontamination. Mechanical means have been demonstrated to be effective in eliminating calculus deposits and residual debris; however, the presence of undercuts and the grooves and porosities along the roughened implant surface make it difficult to achieve an aseptic surface. In conjunction with mechanical measures, use of chemical adjuncts has been advocated to dilute bacterial concentrations, destroy the bacteria’s organic components and eliminate endotoxins. Pharmacological adjuncts have also been recommended to diminish the bacterial load. Other strategies, such as use of lasers, implantoplasty and electrolysis, have been suggested for implant surface decontamination to promote predictable clinical and radiographic outcomes.
Keywords: dental implant, dental implantation, peri-implant endosseous healing, peri-implantitis
Conflict-of-interest statement: The authors declare that they have no direct conflicts of interest. Dr Monje owns royalties to a peri-implantitis kit that includes burs for mechanical detoxi
Ein Review zur lokalen und systemischen antibiotischen Therapie der periimplantären Infektionen
Die Therapie der periimplantären Infektionen stellt aufgrund ihrer Komplexität eine Herausforderung in der täglichen Praxis dar. Lokale/topische und systemische Antibiotika werden überwiegend als Adjuvanzien zum manuellen Debridement und zu alternativen Dekontaminationsverfahren in der nichtchirurgischen und chirurgischen Therapie der periimplantären Infektionen eingesetzt. Aktuelle Daten hinsichtlich ihrer Effizienz sind nach wie vor kontrovers. Im vorliegenden Beitrag wird die derzeitige Evidenz zum Benefit der adjuvanten antibiotischen Therapie bei den nichtchirurgischen und den chirurgischen Behandlungsprotokollen der periimplantären Mukositis und der Periimplantitis vermittelt.
Manuskripteingang:12.04.2022, Annahme: 26.04.2022
Keywords: antibiotische Therapie, periimplatäre Mukositis, Periimplantitis
The tasks of Working Groups 1 to 6 at the 4th Consensus Meeting of the Oral Reconstruction Foundation were to elucidate clinical recommendations for implant-supported full-arch rehabilitations in edentulous patients. Six systematic/ narrative reviews were prepared to address the following subtopics: (1) the influence of medical and geriatric factors on implant survival; (2) the prevalence of peri-implant diseases; (3) the influence of material selection, attachment type, interarch space, and opposing dentition; (4) different interventions for rehabilitation of the edentulous maxilla; (5) different interventions for rehabilitation of the edentulous mandible; and (6) treatment choice and decision-making in elderly patients. Consensus statements, clinical recommendations, and implications for future research were determined based on structured group discussions and plenary session approval.
Purpose: To assess the prevalence of peri-implant diseases (ie, peri-implant mucositis and peri-implantitis) in patients rehabilitated with full-arch, implant-supported restorations.
Materials and Methods: A search protocol was developed to answer the following focus question: What is the prevalence of peri-implant diseases in edentulous patients rehabilitated with implant-supported fixed or removable restorations? RCTs, controlled clinical trials, and prospective studies with at least 12 months of follow-up and a minimum of 10 patients having at least one edentulous arch were searched.
Results: A total of 18 studies (3 RCTs, 1 nonrandomized controlled trial, and 14 prospective studies) were included. According to a single study, the prevalence of peri-implant mucositis in fully edentulous patients was 57%, corresponding to 47% at the implant level. The prevalence of peri-implant mucositis among patients having at least one edentulous arch ranged between 0% and 13.7% of patients, and from 0% to 20% of implants. In fully edentulous patients, the prevalence of peri-implantitis was found to range between 1.5% and 29.7% of patients and between 2.1% and 20.3% of the implants, while the corresponding values among the patients with at least one edentulous arch were 0% to 25% and 0% to 7.2%, respectively.
Conclusion: Edentulous patients (fully edentulous or at least one edentulous arch) restored with either fixed or removable restorations were frequently affected by peri-implant disease.
International Journal of Oral Implantology, 4/2021
PubMed ID (PMID): 34726848Pages 385-399, Language: EnglishMonje, Alberto / Amerio, Ettore / Farina, Roberto / Nart, José / Ramanauskaite, Ausra / Renvert, Stefan / Roccuzzo, Andrea / Salvi, Giovanni E / Schwarz, Frank / Trombelli, Leonardo / Wang, Hom-Lay
Peri-implant diseases at implant sites represent the most considerable concern for many dental clinicians nowadays due to their detrimental effect on implant longevity. Preventive measures include patient education and motivation, supportive peri-implant therapy and routine assessment of the hard and soft tissues. Nevertheless, the reliability of clinical parameters to monitor peri-implant conditions is subject to debate. As such, the primary purpose of the present review was to gain further insight into the diagnostic accuracy of probing as a clinical tool to monitor dental implants and assist clinicians in preventing peri-implant diseases. Studies have recommended periodic probing to monitor the condition of the peri-implant tissues. Increased probing pocket depth, profuse bleeding on probing and suppuration at implants are clinical signs that have been associated with peri-implantitis; thus, if these clinical parameters are present, radiographic assessment is encouraged to make a definitive diagnosis considering potential inaccuracies related to local and/or systemic factors identified in the present review.
Keywords: complications, diagnostic procedure, peri-implantitis, surgical
Conflict-of-interest statement: The authors declare there are no conflicts of interest relating to this study.
Die präimplantologische Rekonstruktion des Alveolarfortsatzes bei komplexen horizontalen und
vertikalen Alveolarkammdefekten stellt eine große Herausforderung dar. Bei dreidimensionaler
Knochenaugmentation mit ausgeprägter vertikaler Komponente wird als Goldstandard der Einsatz
von extraoral entnommenen Knochenblöcken aus der Beckenkammregion angesehen. An
drei Fallbeispielen werden alternativ die Einsatzmöglichkeiten der Schalentechnik mit autologen,
xenogenen und synthetischen Materialien dargestellt. Als vorteilhaft haben sich dabei die Erweiterung
von Behandlungsoptionen zur Weich- und Hartgewebeaugmentation und die Senkung
der Entnahmemorbidität für Patienten erwiesen. Allerdings fehlen noch Langzeitstudien zum
Implantatüberleben, zu den Augmentatresorptionsraten und zum marginalen periimplantären
Knocherverlust. Auch welches Material für die Schale und die entsprechende Füllung bevorzugt
werden soll, ist nicht abschließend geklärt.
Manuskripteingang: 24.08.2021, Annahme: 23.09.2021
Keywords: dreidimensionale Knochenaugmentation, Schalentechnik, SonicWeld Rx, allogene Biomaterialien, xenogene Biomaterialien, azelluläre dermale Matrix